Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

5.49
+0.920020.13%
Post-market: 5.540.0500+0.91%17:46 EDT
Volume:59.94M
Turnover:316.68M
Market Cap:2.23B
PE:-3.02
High:5.52
Open:4.72
Low:4.71
Close:4.57
Loading ...

Recursion Pharmaceuticals and MIT Unveil Boltz-2: Revolutionary AI Model Enhances Drug Discovery with Unmatched Speed and Accuracy

Reuters
·
Yesterday

Nvidia Concept Stocks Jump. Applied Digital up 12%; CoreWeave, RXRX up More Than 8%

Tiger Newspress
·
Yesterday

Nvidia Concept Stocks Mixed. Nebius Soars 16% While CoreWeave Sinks over 11%

Tiger Newspress
·
05 Jun

Recursion Pharmaceuticals call volume above normal and directionally bullish

TIPRANKS
·
04 Jun

Nvidia Concept Stocks Shined. Navitas Soared 13%; CoreWeave And WeRide Surged 8%; Innoviz Up 7%; Nvidia Up 6%

Tiger Newspress
·
29 May

Nvidia Concept Stocks Shined. WeRide surged 20%; CoreWeave and Navitas up 12%; Innoviz and Arbe Robotics up 4%.

Tiger Newspress
·
27 May

Nvidia Concept Stocks Shine. Applied Digital rose 15%; CoreWeave up 13%; RXRX up 6%

Tiger Newspress
·
16 May

Stock Track | Recursion Pharmaceuticals (RXRX) Surges 6.93% in Pre-market: AI-Driven Drug Discovery Attracts Investor Interest

Stock Track
·
12 May

Should You Buy This Beaten-Down Artificial Intelligence (AI) Stock on the Dip?

Motley Fool
·
12 May

Why Recursion Pharmaceuticals Stock Plummeted 24% This Week

Motley Fool
·
10 May

Stock Track | Recursion Pharmaceuticals (RXRX) Soars 5.17% Pre-market Amid Medical AI Sector Strength

Stock Track
·
07 May

Hold Rating for Recursion Pharmaceuticals Amid Program Discontinuations and Financial Concerns

TIPRANKS
·
07 May

24H|Crypto Shares Gain; Canaan up 10%; Riot Platforms up 5%; Medical AI Stocks Rise; RXRX up 4%; Gold Shares Fall

Tiger Newspress
·
07 May

Why Recursion Pharmaceuticals Stock Is Plummeting Today

Motley Fool
·
07 May

Stock Track | Recursion Pharmaceuticals (RXRX) Plummets 5.15% as Analysts Slash Price Targets

Stock Track
·
06 May

Recursion Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $8 From $10

THOMSON REUTERS
·
06 May

Cautious Outlook on Recursion Pharmaceuticals Amid Strategic Shifts and Early-Stage Developments

TIPRANKS
·
06 May

Recursion Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
06 May

Recursion Pharmaceuticals (RXRX) Receives a Hold from TD Cowen

TIPRANKS
·
06 May

Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ), Recursion Pharmaceuticals (RXRX) and Cardinal Health (CAH)

TIPRANKS
·
06 May